Your browser doesn't support javascript.
loading
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Pearson, Andrew D J; Barry, Elly; Mossé, Yael P; Ligas, Franca; Bird, Nick; de Rojas, Teresa; Zimmerman, Zachary F; Wilner, Keith; Woessmann, Willi; Weiner, Susan; Weigel, Brenda; Venkatramani, Rajkumar; Valteau, Dominique; Trahair, Toby; Smith, Malcolm; Singh, Sonia; Selvaggi, Giovanni; Scobie, Nicole; Schleiermacher, Gudrun; Richardson, Nicholas; Park, Julie; Nysom, Karsten; Norga, Koen; Merino, Margret; McDonough, Joe; Matloub, Yousif; Marshall, Lynley V; Lowe, Eric; Lesa, Giovanni; Irwin, Meredith; Karres, Dominik; Gajjar, Amar; Doz, François; Fox, Elizabeth; DuBois, Steven G; Donoghue, Martha; Casanova, Michela; Caron, Hubert; Buenger, Vickie; Bradford, Diana; Blanc, Patricia; Barone, Amy; Reaman, Gregory; Vassal, Gilles.
Afiliação
  • Pearson ADJ; ACCELERATE, Europe. Electronic address: andy1pearson@btinternet.com.
  • Barry E; Day One Biopharmaceuticals, USA.
  • Mossé YP; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, USA.
  • Ligas F; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.
  • Bird N; Solving Kids' Cancer, UK.
  • de Rojas T; ACCELERATE, Europe.
  • Zimmerman ZF; Turning Point Therapeutics, USA.
  • Wilner K; Pfizer, USA.
  • Woessmann W; Medical Center Hamburg-Eppendorf, Germany.
  • Weiner S; Children's Cancer Cause, USA.
  • Weigel B; University of Minnesota, USA.
  • Venkatramani R; Baylor College of Medicine, USA.
  • Valteau D; Gustave Roussy Cancer Centre, France.
  • Trahair T; Sydney Children's Hospital, Australia.
  • Smith M; National Cancer Institute, USA.
  • Singh S; US Food and Drug Administration, USA.
  • Selvaggi G; Xcovery, USA.
  • Scobie N; Zoe4Life, Switzerland.
  • Schleiermacher G; Institute Curie and University of Paris, France.
  • Richardson N; US Food and Drug Administration, USA.
  • Park J; Seattle Children's Hospital, USA.
  • Nysom K; Rigshospitalet, Denmark.
  • Norga K; Antwerp University Hospital, Paediatric Committee of the European Medicines Agency, Federal Agency for Medicines and Health Products, Belgium.
  • Merino M; US Food and Drug Administration, USA.
  • McDonough J; The Andrew McDonough B+ Foundation, USA.
  • Matloub Y; Takeda Pharmaceuticals International, USA.
  • Marshall LV; Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, UK.
  • Lowe E; Children's Hospital of the King's Daughters, USA.
  • Lesa G; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.
  • Irwin M; Hospital for Sick Children, Toronto, Canada.
  • Karres D; Paediatric Medicines Office, Scientific Evidence Generation Department, Human Medicines Division, European Medicines Agency (EMA), Amsterdam, Netherlands.
  • Gajjar A; St Jude Children's Research Hospital, USA.
  • Doz F; Institute Curie and University of Paris, France.
  • Fox E; St Jude Children's Research Hospital, USA.
  • DuBois SG; Dana-Faber Cancer Institute/Harvard Medical School, USA.
  • Donoghue M; US Food and Drug Administration, USA.
  • Casanova M; Istituto Tumori, Italy.
  • Caron H; Hoffmann-La Roche, Switzerland.
  • Buenger V; Coalition Against Childhood Cancer (CAC2), USA.
  • Bradford D; US Food and Drug Administration, USA.
  • Blanc P; Imagine for Margo, France.
  • Barone A; US Food and Drug Administration, USA.
  • Reaman G; US Food and Drug Administration, USA.
  • Vassal G; ACCELERATE, Europe; Gustave Roussy Cancer Centre, France.
Eur J Cancer ; 157: 198-213, 2021 11.
Article em En | MEDLINE | ID: mdl-34536944
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colaboração Intersetorial / Inibidores de Proteínas Quinases / Desenvolvimento de Medicamentos / Quinase do Linfoma Anaplásico / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colaboração Intersetorial / Inibidores de Proteínas Quinases / Desenvolvimento de Medicamentos / Quinase do Linfoma Anaplásico / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article